The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Telfast 30 mg film-coated tablets



Opella Healthcare France SAS T/A SanofiPA23180/003/001

Main Information

Trade NameTelfast 30 mg film-coated tablets
Active SubstancesFexofenadine hydrochloride
Dosage FormFilm-coated tablet
Licence HolderOpella Healthcare France SAS T/A Sanofi
Licence NumberPA23180/003/001

Group Information

ATC CodeR06A ANTIHISTAMINES FOR SYSTEMIC USE

Status

License statusAuthorised
Licence Issued10/02/2004
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back